Meeting Received NDA Submission Planned this Summer KANSAS CITY, Kan., May 14, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc.

May 08, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build ...

Cingulate, Inc. (NASDAQ:CING) reported 2024 results on March 26 th, 2025. No revenues were recorded and operating expense of $15.6 million was recognized. Over the last several months, Cingulate ...

Short interest in Cingulate Inc (NASDAQ:CING) increased during the last reporting period, rising from 171.55K to 223.74K. This put 6.32% of the company's publicly available shares short.

Cingulate (NASDAQ:CING – Get Free Report) had its target price lowered by equities research analysts at Ascendiant Capital Markets from $75.00 to $60.00 in a report released on Monday ...

The latest price target for Cingulate (NASDAQ:CING) was reported by Ascendiant Capital on April 21, 2025. The analyst firm set a price target for $60.00 expecting CING to rise to within 12 months ...

Japanese development studio that created Glass Rose for the PS2, and Another Code for the Nintendo DS. You can find more information about Cing on their website.

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

There are no SEC filings that match your filter(s), please update your selections to return more records. Nasdaq provides company’s SEC filings, which are financial statements and reports filed ...